CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

05 Aug 2025 05:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

30 Jul 2025 05:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

30 Jun 2025 05:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

25 Jun 2025 05:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium

24 Jun 2025 13:05:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

22 May 2025 05:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

19 May 2025 05:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

08 May 2025 05:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update

06 May 2025 05:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

07 Apr 2025 06:56:39 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 Apr 2025 07:04:20 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

01 Apr 2025 07:34:46 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 Mar 2025 06:45:10 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

28 Mar 2025 07:27:20 By NetDania Notify

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

28 Mar 2025 05:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 Mar 2025 06:47:57 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

20 Mar 2025 06:45:04 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

19 Mar 2025 06:50:27 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

18 Mar 2025 08:37:18 By NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

13 Mar 2025 08:52:18 By NetDania Notify